For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer ...

A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next ...

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...

Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...